Skip to content

The effect of Linezolid sequential therapy in children drug resistance and severe tuberculosis

The effect of Linezolid sequential therapy in children drug resistance and severe tuberculosis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042287
Enrollment
Unknown
Registered
2021-01-17
Start date
2021-01-18
Completion date
Unknown
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

durg-resistance group:LZD 10mg/kg twice daily for 3m or relieve of symptoms, followed by 10mg/kg once daily to the end of treatmetn
severe tuberculosis group:LZD 10mg/kg twice daily for 1-2m or relieve of symptoms, followed by 10mg/kg once daily with total treatment duration 2-4m

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Meet the criteria of drug resistance tuberculosis (refer to the WHO Guidance for national tuberculosis programmes on the management of tuberculosis in children (Second Edition) and Guidance of Guidelines for clinical diagnosis and treatment of tuberculosis); 2. Patients who are drug senstive developed drug induced liver injury or patients which severe type tuberculosis including miliary tuberculosis, tuberculosis meningitits,pulmonary tuberculosis with cavities ect.; 3. Age range from 0 to 18 year old; 4. Informed consent are obtained from the guardian and the patients (aged > 8 years).

Exclusion criteria

Exclusion criteria: 1. Patient are allergy to Linezolid, or combined with other conditions that not fit for Linezolid treatment; 2. Paitents unwill to join the study.

Design outcomes

Primary

MeasureTime frame
Symptoms improved and / or etiology turned negative;

Secondary

MeasureTime frame
Incidence of adverse drug reactions;

Countries

China

Contacts

Public ContactZhenzhen Zhang

Children's Hospital of Chongqing Medical University

zhangzhenzhen@cqmu.edu.cn+86 23-68370377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026